Skip to main content
Top
Published in: Digestive Diseases and Sciences 5/2006

01-05-2006 | Original Paper

Hepatocellular Carcinoma Occurring in a Patient with Crohn’s Disease Treated with Both Azathioprine and Infliximab

Authors: Shawn C. Chen, Oscar W. Cummings, Michael P. Hartley, Carol A. Filomena, Won Kyoo Cho

Published in: Digestive Diseases and Sciences | Issue 5/2006

Login to get access

Abstract

Hepatocellular carcinoma is known to be associated with underlying liver diseases, such as cirrhosis, hemochromatosis, and chronic viral hepatitis. All reported cases of hepatocellular carcinoma in association with Crohn’s disease involve patients treated previously with azathioprine or both azathioprine and steroids. However, hepatocellular carcinoma associated with the use of azathioprine and infliximab has not been reported. In this report, we describe an unusual case of hepatocellular carcinoma and focal hepatic glycogenosis (FHG) occurring in a non-cirrhotic Crohn’s disease patient who has been treated with both azathioprine and infliximab.
Literature
1.
go back to reference Lee FL, Murray SM, Prior J, Shreeve DR (1983) Primary liver cell cancer occurring in association with Crohn’s disease treated with prednisolone and azathioprine. Hepatogastroenterology 30:188PubMed Lee FL, Murray SM, Prior J, Shreeve DR (1983) Primary liver cell cancer occurring in association with Crohn’s disease treated with prednisolone and azathioprine. Hepatogastroenterology 30:188PubMed
2.
go back to reference Cattan S, Wendum D, Chazouilleres O, Schmitz J, Gendre JP (2000) Hepatocellular carcinoma and focal hepatic glycogenosis after prolonged azathioprine therapy. Hum Pathol 31:874–876PubMedCrossRef Cattan S, Wendum D, Chazouilleres O, Schmitz J, Gendre JP (2000) Hepatocellular carcinoma and focal hepatic glycogenosis after prolonged azathioprine therapy. Hum Pathol 31:874–876PubMedCrossRef
3.
go back to reference Gruber S, Dehner LP, Simmons RL (1987) De novo hepatocellular carcinoma without chronic liver disease but with 17 years of azathioprine immunosuppression. Transplantation 43:597–600PubMedCrossRef Gruber S, Dehner LP, Simmons RL (1987) De novo hepatocellular carcinoma without chronic liver disease but with 17 years of azathioprine immunosuppression. Transplantation 43:597–600PubMedCrossRef
4.
go back to reference Saeian K, Franco J, Komorowski RA, Adams MB (1999) Hepatocellular carcinoma after renal transplantation in the absence of cirrhosis or viral hepatitis: a case series. Liver Transpl Surg 5:46–49PubMedCrossRef Saeian K, Franco J, Komorowski RA, Adams MB (1999) Hepatocellular carcinoma after renal transplantation in the absence of cirrhosis or viral hepatitis: a case series. Liver Transpl Surg 5:46–49PubMedCrossRef
5.
go back to reference Borum ML (2001) Unusual development of hepatocellular carcinoma in a patient with Crohn’s disease. Dig Dis Sci 46:2199–2200PubMedCrossRef Borum ML (2001) Unusual development of hepatocellular carcinoma in a patient with Crohn’s disease. Dig Dis Sci 46:2199–2200PubMedCrossRef
6.
go back to reference Russmann S, Zimmermann A, Krähenbühl S, Kern B, Reichen J (2001) Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis. Eur J Gastroenterol Hepatol 13:287–290PubMedCrossRef Russmann S, Zimmermann A, Krähenbühl S, Kern B, Reichen J (2001) Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis. Eur J Gastroenterol Hepatol 13:287–290PubMedCrossRef
7.
go back to reference MacSween RNM, Burt AD, Portmann BC, Ishak KG, Scheuer PJ, Anthony PP (2002) Pathology of liver, 4th ed. Churchchill Livingstone, New York MacSween RNM, Burt AD, Portmann BC, Ishak KG, Scheuer PJ, Anthony PP (2002) Pathology of liver, 4th ed. Churchchill Livingstone, New York
8.
go back to reference Esser AC, Abril A, Fayne S, Doyle JA (2004) Acute development of multiple keratoacanthomas and squamous cell carcinomas after treatment with infliximab. J Am Acad Dermatol 50:S75–S77PubMedCrossRef Esser AC, Abril A, Fayne S, Doyle JA (2004) Acute development of multiple keratoacanthomas and squamous cell carcinomas after treatment with infliximab. J Am Acad Dermatol 50:S75–S77PubMedCrossRef
Metadata
Title
Hepatocellular Carcinoma Occurring in a Patient with Crohn’s Disease Treated with Both Azathioprine and Infliximab
Authors
Shawn C. Chen
Oscar W. Cummings
Michael P. Hartley
Carol A. Filomena
Won Kyoo Cho
Publication date
01-05-2006
Published in
Digestive Diseases and Sciences / Issue 5/2006
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-005-9009-9

Other articles of this Issue 5/2006

Digestive Diseases and Sciences 5/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.